KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) EBIT (2020 - 2025)

Oscar Health (OSCR) has disclosed EBIT for 6 consecutive years, with $232.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT rose 369.72% year-over-year to $232.1 million, compared with a TTM value of $202.9 million through Dec 2025, up 254.39%, and an annual FY2025 reading of $202.9 million, up 254.39% over the prior year.
  • EBIT was $232.1 million for Q4 2025 at Oscar Health, up from -$129.2 million in the prior quarter.
  • Across five years, EBIT topped out at $395.0 million in Q4 2022 and bottomed at -$332.4 million in Q4 2023.
  • Average EBIT over 5 years is $12.6 million, with a median of $1.0 million recorded in 2021.
  • The sharpest move saw EBIT soared 19241.88% in 2021, then tumbled 3739.17% in 2023.
  • Year by year, EBIT stood at $292.8 million in 2021, then surged by 34.88% to $395.0 million in 2022, then tumbled by 184.16% to -$332.4 million in 2023, then soared by 74.12% to -$86.0 million in 2024, then surged by 369.72% to $232.1 million in 2025.
  • Business Quant data shows EBIT for OSCR at $232.1 million in Q4 2025, -$129.2 million in Q3 2025, and $54.0 million in Q2 2025.